[#item_full_content] California’s top marijuana regulator says the Drug Enforcement Administration (DEA) hasn’t been cooperative in answering questions about the implications of the Trump administration’s rescheduling move—while the federal agency is simultaneously asking the state itself to share more information about its medical cannabis program. “We have received no formal updates from DEA headquarters on implementation guidance
Read More